Related Experiment Video
Updated: Aug 7, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Epidemiology of Clostridioides difficile Infections in Germany, 2010-2019: A Review from Four Public Databases
Gordon Brestrich1, Frederick J Angulo2, Fabian K Berger3,4
1Pfizer Pharma GmbH, Berlin, Germany. Gordon.brestrich@pfizer.com.
Clostridioides difficile infection (CDI) incidence in Germany peaked in 2013 and declined by 2019, yet the disease burden remains significant. Continued attention is crucial for this severe public health challenge.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Clostridioides difficile infection (CDI) poses a global threat, particularly to vulnerable populations.
- It presents challenges in both hospital and community settings due to severe courses, recurrence, high mortality, and significant healthcare costs.
- The CDI burden in Germany has been analyzed using data from four public databases.
Purpose of the Study:
- To analyze and compare the hospital burden of CDI in Germany from 2010-2019.
- To compare CDI-related hospital days with those of vaccine-preventable diseases like influenza and herpes zoster.
- To compare German CDI hospitalizations with those in the United States.
Main Methods:
- Data extraction and comparison from four public databases for CDI hospital burden (2010-2019).
- Analysis of CDI patient days and comparison with influenza and herpes zoster.
- Comparison of CDI hospitalization incidence between Germany and the US.
Main Results:
- Comparable incidences and trends were reported across all four databases.
- Hospitalized CDI incidence increased to a peak in 2013, then declined by 2019.
- The majority of hospitalized CDI patients were over 50 years old, with significant patient days exceeding those for influenza and herpes zoster in many years.
- CDI mortality exceeded 1,000 deaths annually, and German hospitalization rates were higher than in the US.
Conclusions:
- Despite a documented decline in CDI cases since 2013, the overall disease burden remains substantial.
- CDI continues to be a severe public health challenge requiring ongoing attention.
- Further research and public health interventions are warranted to mitigate the impact of CDI.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Development of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

